Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients

被引:88
作者
Hashimoto, Kenji [1 ]
Engberg, Goran [2 ]
Shimizu, Eiji [1 ]
Nordin, Conny [3 ]
Lindstrom, Leif H. [4 ]
Iyo, Masaomi [1 ]
机构
[1] Chiba Univ, Grad Sch Med, Dept Psychiat, Chiba 2608670, Japan
[2] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden
[3] Linkoping Univ Hosp, Div Psychiat, Dept Neurosci & Locomot, S-58185 Linkoping, Sweden
[4] Uppsala Univ, Vasteras Cent Hosp, Dept Psychiat Res, Vasteras, Sweden
关键词
Glutamate; Schizophrenia; High Performance Liquid Chromatography; Glutamine; Glutamine Synthetase;
D O I
10.1186/1471-244X-5-6
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Recent magnetic resonance spectroscopy (MRS) studies report that glutamine is altered in the brains of schizophrenic patients. There were also conflicting findings on glutamate in cerebrospinal fluid (CSF) of schizophrenic patients, and absent for glutamine. This study aims to clarify the question of glutamine and glutamate in CSF of first episode and drug naive schizophrenic patients. Method: Levels of glutamine and glutamate in CSF of 25 first episode and drug-naive male schizophrenic patients and 17 age-matched male healthy controls were measured by a high performance liquid chromatography. Results: The ratio (126.1 (median), 117.7 +/- 27.4 (mean +/- S. D.)) of glutamine to glutamate in the CSF of patients was significantly (z = -3.29, p = 0.001) higher than that (81.01 (median), 89.1 +/- 22.5 (mean +/- S. D.)) of normal controls although each level of glutamine and glutamate in patients was not different from that of normal controls. Conclusion: Our data suggests that a disfunction in glutamate-glutamine cycle in the brain may play a role in the pathophysiology of schizophrenia.
引用
收藏
页数:5
相关论文
共 22 条
[1]   GLUTAMATE AND GLUTAMINE IN CEREBROSPINAL-FLUID AND SERUM FROM HEALTHY-VOLUNTEERS - ANALYTICAL ASPECTS [J].
ALFREDSSON, G ;
WIESEL, FA ;
LINDBERG, M .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1988, 424 (02) :378-384
[2]   A fully automated amino acid analyzer using NBD-F as a fluorescent derivatization reagent [J].
Aoyama, C ;
Santa, T ;
Tsunoda, M ;
Fukushima, T ;
Kitada, C ;
Imai, K .
BIOMEDICAL CHROMATOGRAPHY, 2004, 18 (09) :630-636
[3]  
Bartha R, 1997, ARCH GEN PSYCHIAT, V54, P959
[4]   Glutamine synthetase and glutamate dehydrogenase in the prefrontal cortex of patients with schizophrenia [J].
Burbaeva, GS ;
Boksha, IS ;
Turischeva, MS ;
Vorobyeva, EA ;
Savushkina, OK ;
Tereshkina, EB .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2003, 27 (04) :675-680
[5]   Mind glue -: Implications of glial cell biology for psychiatry [J].
Coyle, JT ;
Schwarcz, R .
ARCHIVES OF GENERAL PSYCHIATRY, 2000, 57 (01) :90-93
[6]   GAMMA-GLUTAMYLGLUTAMINE AND TAURINE CONCENTRATIONS ARE DECREASED IN THE CEREBROSPINAL-FLUID OF DRUG-NAIVE PATIENTS WITH SCHIZOPHRENIC DISORDERS [J].
DO, KQ ;
LAUER, CJ ;
SCHREIBER, W ;
ZOLLINGER, M ;
GUTTECKAMSLER, U ;
CUENOD, M ;
HOLSBOER, F .
JOURNAL OF NEUROCHEMISTRY, 1995, 65 (06) :2652-2662
[7]   Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia [J].
Erhardt, S ;
Blennow, K ;
Nordin, C ;
Skogh, E ;
Lindström, LH ;
Engberg, G .
NEUROSCIENCE LETTERS, 2001, 313 (1-2) :96-98
[8]   Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients [J].
Gluck, MR ;
Thomas, RG ;
Davis, KL ;
Haroutunian, V .
AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (07) :1165-1173
[9]   The emerging role of glutamate in the pathophysiology and treatment of schizophrenia [J].
Goff, DC ;
Coyle, JT .
AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (09) :1367-1377
[10]  
Hashimoto K, 2005, CURR PSYCHI IN PRESS